Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Treating cystoid macular oedema in uveitis is difficult and risky.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.